Humana Inc vs SoundHound AI Inc — how do they compare? Humana Inc trades at $445 (market cap $46.49B), while SoundHound AI Inc trades at $5.56 (market cap $2.45B). The key difference: Humana Inc is far larger — about 19× SoundHound AI Inc's market cap, and Humana Inc pays a 0.91% dividend while SoundHound AI Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and SoundHound AI Inc for 23 Days on average.
| HUM | SOUN | |
|---|---|---|
Market Cap | $46.49B | $2.45B |
Volume | 2,567,704 | 16,881,989 |
Sector | Health | Technology |
52-Week High | $409.85 | $21.40 |
52-Week Low | $163.67 | $5.52 |
Typical Hold Time | 53 Days | 23 Days |
Enterprise Value | $53.84B | $2.25B |
Dividend Yield | 0.91% | — |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $396.51, down 1.92% on the day, with strong technical momentum showing bullish moving averages and key support at $391. The company demonstrates consistent revenue growth reaching $129.7B in 2025, though net margins have compressed to 0.88%. Recent quarterly earnings have exceeded expectations, with Q2 2026 EPS of $7.61 beating estimates of $7.27. Analyst sentiment remains positive with a $432.63 consensus price target representing 9% upside potential from current levels.
The investment case centers on Humana's dominant Medicare Advantage position and consistent revenue growth, though margin pressure and regulatory scrutiny present headwinds. With 43% of analysts maintaining buy ratings and institutional accumulation continuing, the stock offers exposure to healthcare demographics but requires monitoring of enrollment trends and cost management execution.
SoundHound AI (SOUN) trades at $5.63, down 1.57% today, with a bearish technical signal despite recent earnings beats. The company shows strong revenue growth ($169M in 2025, projected $203M in 2026) but significant net losses (-$14M in 2025, -$137M projected in 2026). Recent developments include expansion into banking AI agents and the OASYS Edge embedded architecture launch for vehicles and smart devices (GlobeNewsWire, September 24, 2026).
Investment outlook balances high growth potential against substantial profitability challenges. Analyst consensus is bullish with a $9.33 price target (75% buy ratings), but negative cash flow from operations and insider selling pose near-term risks. The stock's success depends on converting revenue growth to profitability while managing integration risks from acquisitions.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →